fda tirzepatide decision to reconsider removal of Eli Lilly weight loss drug from shortage list Compounders protest as FDA removes

Receive your monthly medication with all supplies directly from a reputable Legit Script Certified U.S

Wegovy cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease Novo Nordisk Novo Nordisk presented data from the STEER real-world study of evidence gathered from actual patient experiences at the European Society of Cardiology (ESC) Congress 2025 in Madrid, Spain

However, 'better' on paper does not always mean 'better' for every individualsome patients tolerate semaglutide's single-pathway mechanism more comfortably

Each represents a potential litigation target or licensing negotiation point as the base composition of matter patents expire and biosimilar/generic developers assess freedom to operate